New York State Common Retirement Fund Boosts Stake in Definitive Healthcare Corp. (NASDAQ:DH)

New York State Common Retirement Fund raised its position in Definitive Healthcare Corp. (NASDAQ:DH) by 17.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 336,859 shares of the company’s stock after purchasing an additional 50,762 shares during the quarter. New York State Common Retirement Fund owned 0.29% of Definitive Healthcare worth $3,348,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in DH. Bank of New York Mellon Corp raised its holdings in shares of Definitive Healthcare by 11.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,090,136 shares of the company’s stock valued at $8,710,000 after buying an additional 113,963 shares during the period. Vanguard Group Inc. lifted its position in shares of Definitive Healthcare by 6.2% during the third quarter. Vanguard Group Inc. now owns 4,331,543 shares of the company’s stock worth $34,609,000 after purchasing an additional 254,726 shares in the last quarter. Eagle Asset Management Inc. boosted its stake in shares of Definitive Healthcare by 7.5% in the third quarter. Eagle Asset Management Inc. now owns 784,230 shares of the company’s stock valued at $6,266,000 after purchasing an additional 54,590 shares during the period. Raymond James & Associates grew its holdings in shares of Definitive Healthcare by 24.2% in the third quarter. Raymond James & Associates now owns 650,327 shares of the company’s stock valued at $5,196,000 after purchasing an additional 126,613 shares in the last quarter. Finally, Victory Capital Management Inc. grew its holdings in shares of Definitive Healthcare by 68.4% in the third quarter. Victory Capital Management Inc. now owns 269,433 shares of the company’s stock valued at $2,153,000 after purchasing an additional 109,463 shares in the last quarter. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Definitive Healthcare Stock Up 0.6 %

DH opened at $7.03 on Monday. The stock has a market capitalization of $828.06 million, a P/E ratio of -3.95, a price-to-earnings-growth ratio of 6.12 and a beta of 1.41. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. Definitive Healthcare Corp. has a one year low of $5.53 and a one year high of $12.45. The business’s 50-day simple moving average is $7.85 and its 200-day simple moving average is $8.31.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. The business had revenue of $65.93 million during the quarter, compared to analyst estimates of $66.01 million. Analysts anticipate that Definitive Healthcare Corp. will post 0.11 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have commented on DH. Stifel Nicolaus decreased their price target on shares of Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating for the company in a research report on Wednesday, January 17th. Needham & Company LLC downgraded Definitive Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, January 17th. Canaccord Genuity Group boosted their price objective on Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a research report on Thursday, February 29th. Finally, Barclays boosted their price target on shares of Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a report on Friday, March 1st. Seven equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, Definitive Healthcare presently has a consensus rating of “Hold” and an average target price of $11.31.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.